Azelastini hydrochloridum, Fluticasoni propionas

Medicinal product name Dymista 137 micrograms/50 micrograms per actuation nasal spray, suspension
Pharmaceutical form Nasal spray, suspension
Strength 137 micrograms/50 micrograms per actuation 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
13-0044-02N120: 1 × 120 Is available
Legal status Rx Prescription (Pr.)
Package leafletPDF 31-01-2023
Summary of product characteristicsPDF 31-01-2023
ATC code R01AD58 Nasal preparations
Information for Marketing authorisation holdersView

Medicinal products (4)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28: 1 × 28
(137 µg/50 µg/dose)
Glass bottle (amber)    13-0044-01 Labelling text Labelling text Jan 31, 2023
Labelling text Labelling text Jan 31, 2023
 Is available (according to the information provided by wholesalers)
(2303 containers)
Tamro, Recipe Plus, Magnum Medical, Euroaptieka, Jelgavfarm, Medelens+, Oribalt Rīga N120: 1 × 120
(137 µg/50 µg/dose)
Glass bottle (amber) 21.95  13-0044-02 Labelling text Labelling text Jan 31, 2023
Labelling text Labelling text Jan 31, 2023
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N280: 10 × 28
(137 µg/50 µg/dose)
Glass bottle (amber)    13-0044-03 Labelling text Labelling text Jan 31, 2023
Labelling text Labelling text Jan 31, 2023
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N360: 3 × 120
(137 µg/50 µg/dose)
Glass bottle (amber)    13-0044-04 Labelling text Labelling text Jan 31, 2023
Labelling text Labelling text Jan 31, 2023

Registration information

Marketing authorisation No. 13-0044
Date of authorisation Mar 8, 2013
Marketing authorisation holder, country Viatris Healthcare Limited, Ireland